{"variationId": "226036", "variationName": "NM_003783.3(B3GALT2):c.367T>G (p.Tyr123Asp)", "variationType": "single nucleotide variant", "dateCreated": "2016-05-21T00:00:00Z", "dateLastUpdated": "2023-12-25T00:00:00Z", "mostRecentSubmission": "2016-05-21T00:00:00Z", "accession": "VCV000226036", "version": 2, "numberOfSubmitters": 1, "numberOfSubmissions": 1, "recordType": "RECORD_TYPE_CLASSIFIED", "recordStatus": "RECORD_STATUS_CURRENT", "species": {"name": "Homo sapiens"}, "classifiedRecord": {"simpleAllele": {"genes": [{"locations": [{"cytogeneticLocations": ["1q31.2"], "sequenceLocations": [{"assembly": "GRCh38", "chr": "CHROMOSOME_1", "accession": "NC_000001.11", "start": 193178730, "stop": 193186613, "displayStart": 193178730, "displayStop": 193186613, "strand": "-"}, {"assembly": "GRCh37", "chr": "CHROMOSOME_1", "accession": "NC_000001.10", "start": 193147859, "stop": 193155742, "displayStart": 193147859, "displayStop": 193155742, "strand": "-"}]}], "omims": ["603018"], "fullName": "beta-1,3-galactosyltransferase 2", "geneId": "8707", "hgncId": "HGNC:917", "source": "submitted", "relationshipType": "GENE_VARIANT_RELATIONSHIP_WITHIN_MULTIPLE_GENES_BY_OVERLAP"}, {"locations": [{"cytogeneticLocations": ["1q31.2"], "sequenceLocations": [{"assembly": "GRCh38", "chr": "CHROMOSOME_1", "accession": "NC_000001.11", "start": 193122031, "stop": 193254815, "displayStart": 193122031, "displayStop": 193254815, "strand": "+"}, {"assembly": "GRCh37", "chr": "CHROMOSOME_1", "accession": "NC_000001.10", "start": 193091087, "stop": 193223944, "displayStart": 193091087, "displayStop": 193223944, "strand": "+"}]}], "omims": ["607393"], "haploinsufficiency": {"value": "Sufficient evidence for dosage pathogenicity", "lastEvaluated": "2022-04-13T00:00:00Z", "clingen": "https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73"}, "triplosensitivity": {"value": "No evidence available", "lastEvaluated": "2022-04-13T00:00:00Z", "clingen": "https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73"}, "fullName": "cell division cycle 73", "geneId": "79577", "hgncId": "HGNC:16783", "source": "submitted", "relationshipType": "GENE_VARIANT_RELATIONSHIP_WITHIN_MULTIPLE_GENES_BY_OVERLAP"}], "name": "NM_003783.3(B3GALT2):c.367T>G (p.Tyr123Asp)", "canonicalSpdi": "NC_000001.11:193181195:A:C", "variantTypes": ["single nucleotide variant"], "locations": [{"cytogeneticLocations": ["1q31.2"], "sequenceLocations": [{"forDisplay": true, "assembly": "GRCh38", "chr": "CHROMOSOME_1", "accession": "NC_000001.11", "start": 193181196, "stop": 193181196, "displayStart": 193181196, "displayStop": 193181196, "variantLength": 1, "positionVcf": 193181196, "referenceAlleleVcf": "A", "alternateAlleleVcf": "C"}, {"assembly": "GRCh37", "chr": "CHROMOSOME_1", "accession": "NC_000001.10", "start": 193150326, "stop": 193150326, "displayStart": 193150326, "displayStop": 193150326, "variantLength": 1, "positionVcf": 193150326, "referenceAlleleVcf": "A", "alternateAlleleVcf": "C"}]}], "proteinChanges": ["Y123D"], "hgvsExpressions": [{"nucleotideExpression": {"expression": "NC_000001.10:g.193150326A>C", "sequenceAccessionVersion": "NC_000001.10", "sequenceAccession": "NC_000001", "sequenceVersion": 10, "change": "g.193150326A>C"}, "type": "HGVS_TYPE_GENOMIC_TOP_LEVEL", "assembly": "GRCh37"}, {"nucleotideExpression": {"expression": "NC_000001.11:g.193181196A>C", "sequenceAccessionVersion": "NC_000001.11", "sequenceAccession": "NC_000001", "sequenceVersion": 11, "change": "g.193181196A>C"}, "type": "HGVS_TYPE_GENOMIC_TOP_LEVEL", "assembly": "GRCh38"}, {"nucleotideExpression": {"expression": "NG_012691.1:g.64239A>C", "sequenceAccessionVersion": "NG_012691.1", "sequenceAccession": "NG_012691", "sequenceVersion": 1, "change": "g.64239A>C"}, "type": "HGVS_TYPE_GENOMIC"}, {"nucleotideExpression": {"expression": "NG_052990.1:g.10418T>G", "sequenceAccessionVersion": "NG_052990.1", "sequenceAccession": "NG_052990", "sequenceVersion": 1, "change": "g.10418T>G"}, "type": "HGVS_TYPE_GENOMIC"}, {"nucleotideExpression": {"expression": "NM_003783.3:c.367T>G", "sequenceAccessionVersion": "NM_003783.3", "sequenceAccession": "NM_003783", "sequenceVersion": 3, "change": "c.367T>G", "maneSelect": true}, "proteinExpression": {"expression": "NP_003774.1:p.Tyr123Asp", "sequenceAccessionVersion": "NP_003774.1", "sequenceAccession": "NP_003774", "sequenceVersion": 1, "change": "p.Tyr123Asp"}, "molecularConsequences": [{"db": "SO", "id": "SO:0001583", "type": "missense variant"}], "type": "HGVS_TYPE_CODING"}, {"nucleotideExpression": {"expression": "NM_024529.5:c.973-22599A>C", "sequenceAccessionVersion": "NM_024529.5", "sequenceAccession": "NM_024529", "sequenceVersion": 5, "change": "c.973-22599A>C", "maneSelect": true}, "molecularConsequences": [{"db": "SO", "id": "SO:0001627", "type": "intron variant"}], "type": "HGVS_TYPE_CODING"}, {"nucleotideExpression": {"expression": "LRG_507:g.64239A>C", "sequenceAccessionVersion": "LRG_507", "sequenceAccession": "LRG_507"}, "type": "HGVS_TYPE_GENOMIC"}], "xrefs": [{"db": "ClinGen", "id": "CA1303641"}, {"db": "dbSNP", "id": "41265203", "type": "rs"}], "globalMinorAlleleFrequency": {"value": 0.0006, "source": "1000 Genomes Project", "minorAllele": "C"}, "alleleId": "227841", "variationId": "226036"}, "rcvList": {"rcvAccessions": [{"classifiedConditionList": {"classifiedConditions": [{"value": "Hyperparathyroidism 2 with jaw tumors", "db": "MedGen", "id": "C1704981"}], "traitSetId": "833"}, "rcvClassifications": {"germlineClassification": {"reviewStatus": "AGGREGATE_GERMLINE_REVIEW_STATUS_CRITERIA_PROVIDED_SINGLE_SUBMITTER", "description": {"value": "Likely benign", "dateLastEvaluated": "2015-03-11T00:00:00Z", "submissionCount": 1}}}, "title": "NM_003783.3(B3GALT2):c.367T>G (p.Tyr123Asp) AND Hyperparathyroidism 2 with jaw tumors", "accession": "RCV000211442", "version": 2}]}, "classifications": {"germlineClassification": {"reviewStatus": "AGGREGATE_GERMLINE_REVIEW_STATUS_CRITERIA_PROVIDED_SINGLE_SUBMITTER", "description": "Likely benign", "conditions": [{"traits": [{"names": [{"value": "Hyperparathyroidism 2 with jaw tumors", "type": "Preferred", "xrefs": [{"db": "MONDO", "id": "MONDO:0007768"}]}, {"value": "HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "145001", "type": "MIM"}]}, {"value": "HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "145001", "type": "MIM"}]}, {"value": "Hyperparathyroidism 2", "type": "Alternate", "xrefs": [{"db": "Genetic Alliance", "id": "Hyperparathyroidism+2/8598"}]}], "symbols": [{"value": "HPT-JT", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "145001", "type": "MIM"}]}, {"value": "HRPT2", "type": "Alternate", "xrefs": [{"db": "OMIM", "id": "145001", "type": "MIM"}]}], "attributes": [{"attribute": {"base": {"value": "CDC73-Related Disorders"}, "type": "keyword"}, "xrefs": [{"db": "GeneReviews", "id": "226120"}]}, {"attribute": {"base": {"value": "The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified."}, "type": "public definition"}, "xrefs": [{"db": "GeneReviews", "id": "NBK3789"}]}, {"attribute": {"base": {"integerValue": "10829"}, "type": "GARD id"}, "xrefs": [{"db": "Office of Rare Diseases", "id": "10829"}]}], "citations": [{"ids": [{"value": "20301471", "source": "PubMed"}, {"value": "NBK1294", "source": "BookShelf"}], "type": "review", "abbrev": "GeneReviews"}, {"ids": [{"value": "20301744", "source": "PubMed"}, {"value": "NBK3789", "source": "BookShelf"}], "type": "review", "abbrev": "GeneReviews"}], "xrefs": [{"db": "Orphanet", "id": "99880"}, {"db": "MedGen", "id": "C1704981"}, {"db": "MONDO", "id": "MONDO:0007768"}, {"db": "OMIM", "id": "145001", "type": "MIM"}]}], "type": "TYPE_DISEASE", "id": "833", "contributesToAggregateClassification": true}], "dateLastEvaluated": "2015-03-11T00:00:00Z", "dateCreated": "2016-05-21T00:00:00Z", "mostRecentSubmission": "2016-05-21T00:00:00Z", "numberOfSubmitters": 1, "numberOfSubmissions": 1}}, "clinicalAssertions": [{"clinvarSubmissionId": {"localKey": "UWMG_6788739|MedGen:C1704981", "submittedAssembly": "GRCh37"}, "clinvarAccession": {"accession": "SCV000212171", "version": 1, "submitterIdentifiers": {"submitterName": "CSER _CC_NCGL, University of Washington", "orgId": "505295", "orgCategory": "laboratory", "orgAbbreviation": "CSER _CC_NCGL"}, "dateUpdated": "2016-05-21T00:00:00Z", "dateCreated": "2016-05-21T00:00:00Z"}, "recordStatus": "RECORD_STATUS_CURRENT", "classifications": {"reviewStatus": "SUBMITTER_REVIEW_STATUS_CRITERIA_PROVIDED_SINGLE_SUBMITTER", "germlineClassification": "Likely benign", "dateLastEvaluated": "2015-03-11T00:00:00Z"}, "assertion": "ASSERTION_VARIATION_TO_DISEASE", "attributes": [{"attribute": {"value": "Autosomal dominant inheritance"}, "type": "TYPE_MODE_OF_INHERITANCE"}, {"attribute": {"value": "Amendola et al. (Genome Res. 2015)"}, "type": "TYPE_ASSERTION_METHOD", "citations": [{"ids": [{"value": "25637381", "source": "PubMed"}]}]}], "observedIns": [{"sample": {"origin": "ORIGIN_GERMLINE", "species": {"name": "human", "taxonomyId": 9606}, "affectedStatus": "AFFECTED_STATUS_UNKNOWN", "indication": {"traits": [{"names": [{"value": "adults with personal and/or family history of colorectal cancer and/or polyps", "type": "Preferred"}]}], "type": "TYPE_INDICATION"}}, "observedData": [{"attributes": [{"base": {"value": "not provided"}, "type": "TYPE_DESCRIPTION"}]}]}], "simpleAllele": {"genes": [{"symbol": "B3GALT2"}, {"symbol": "CDC73"}], "variantType": "Variation", "otherNames": [{"value": "NM_003783.3:c.367T>G"}], "xrefs": [{"db": "dbSNP", "id": "41265203", "type": "rsNumber"}], "attributes": [{"attribute": {"base": {"value": "NC_000001.10:g.193150326A>C"}, "type": "HGVS"}}]}, "traitSet": {"traits": [{"names": [{"value": "Hyperparathyroidism-jaw tumor syndrome", "type": "Preferred"}], "xrefs": [{"db": "MedGen", "id": "C1704981", "type": "CUI"}]}], "type": "TYPE_DISEASE"}, "studyName": "CSER - NEXT Medicine variant annotation", "studyDescription": "Diagnostic and incidental finding variants identified by exome sequencing in participants having clinical genetic testing for hereditary colorectal cancer and/or polyps", "submissionNames": ["NEXT_V01_2"], "id": "504204"}], "traitMappings": [{"medgens": [{"name": "Hyperparathyroidism 2 with jaw tumors", "cui": "C1704981"}], "clinicalAssertionId": "504204", "traitType": "Disease", "mappingType": "MAPPING_TYPE_NAME", "mappingValue": "Hyperparathyroidism-jaw tumor syndrome", "mappingRef": "Preferred"}]}}
